Replies to post #32772 on Amarin Corp Plc (AMRN)

[Whalatane]

Ifreak

Well re the FDA ...thats what we are about to find out....does the preponderance of evidence ..particularly the new NEJM research , articles in Lancet etc ...sway the FDA enough to at least expand the label for Vascepa and thus allow more on label scripts and insurance coverage .

Thats the question .. I'm betting it finally does ..thus I have a long position. But its a gamble I do admit.
Do your own DD and don't risk more then you can afford to lose.

Re Wall street ... the reward is from profiting from the unexpected .
If Wall St figured it was a sure thing then the stock would already be higher

The best analogy I can give you is the reaction when we got the Anchor trial results .
Lowering TG's AND lowering LDL at 4 gms of Vascepa , while on Statins , was unexpected ..Wall st responded accordingly

Kiwi

[rafunrafun]

The pps rose 35% over the past 3 months, that is due to all the positive articles, whose significance you dismiss.